Insider filing · ELVN
Richard A. Heyman
Director
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 61 filings in 24 months
ticker →
Richard A. Heyman sold $308K of Enliven Therapeutics (ELVN)
Executed Jan 8, disclosed Jan 12, 4 days later.
Value, as filed
$308K
12,300 sh across 2 lots
Executed
Jan 8
the trade date, as filed
Disclosed
Jan 12
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RHRichard A. Heyman (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $308K of ELVN (12,300 sh across 2 lots, as filed), executed Jan 8.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→